Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity.
Munroe, Melissa E, Kendra Young, Rufei Lu, Joel M Guthridge, Diane L Kamen, Gary S Gilkeson, Michael H Weisman, et al. 2025. “Dysregulated Soluble Immune Mediators and Lupus-Associated Autoantibody Specificities Inform the Development of Immune Indexes That Characterise Classified SLE Transition and SLE Disease Activity.”. Lupus Science & Medicine 12 (2).